Summary
Platelet aggregation in response to collagen, adenosine diphosphate and arachidonic acid was studied prospectively in 30 children with Type 1 (insulin-dependent) diabetes mellitus. The studies began on admission to hospital and continued throughout the two years following diagnosis. The results were compared with those in 44 healthy control children. Collagen-induced aggregation was significantly decreased in the diabetic children on admission in comparison to the healthy children. In contrast, the aggregation induced by adenosine diphosphate (1.1 μmol/l, p<0.05) and arachidonic acid (0.25 mmol/l, p<0.05) was increased on admission. The magnitude of the platelet shape change after adenosine diphosphate stimulation was small at the onset of the disease but was significantly increased towards normal during the two years of follow-up. On admission, the primary wave aggregation induced by adenosine diphosphate was positively and significantly correlated to some of the lipoprotein fractions that were disturbed at that time, especially triglycerides in high-density lipoproteins. After two years of treatment the platelet aggregability in the diabetic children had been restored to normal.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Colwell JA, Winocour PD, Halushka PV (1983) Do platelets have anything to do with diabetic microvascular disease? Diabetes 32 [Suppl. 2]: 14–19
Schernthaner G, Sinzinger H, Silberbauer K, Freyler H, Muhlhauser I, Kaliman J (1981) Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet specific proteins in diabetes mellitus. Horm Metab Res 33 [Suppl. 1]: 33–43
Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314: 488–500
Halushka PV, Lurie D, Colwell JA (1977) Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med 297: 1306–1310
Kwaan HC, Colwell JA, Cruz S, Suwanwela N, Dobbie JG (1972) Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 80: 236–246
Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Int Med 82: 733–738
Johnson M, Harrison HE, Raftly AT, Elder JB (1979) Vascular prostacyclin may be reduced in diabetes in man. Lancet I: 325–326
Gerrard JM, Stuart MJ, Rao GHR, Steffes MW, Mauer SM, Bronn DM, White JG (1980) Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 95: 950–958
Silberbauer K, Schernthaner G, Sinzinger H, Piza-Katzer H, Winter M (1979) Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med 300: 366–367
Paton RC (1979) Platelet survival in diabetes mellitus using an aspirin labelling technique. Thromb Res 15: 793–802
Burrows AW, Chavin SI, Hockaday TDR (1978) Plasma-thromboglobulin concentrations in diabetes mellitus. Lancet I: 235–237
Halushka PV, Mayfield R, Colwell JA (1985) Insulin and arachidonic acid metabolism in diabetes mellitus. Metabolism 34: 32–36
Harrison HE, Reece AH, Johnson M (1978) Decreased vascular prostacyclin in experimental diabetes. Lif Sci 23: 351–355
Almér L, Nilson IM (1975) Fibrinolysis in diabetes mellitus. Acta Med Scand 198: 101–106
Almér L, Pandolfi M (1976) Fibrinolysis and retinopathy. Diabetes 25 [Suppl. 2]: 807–810
Shattil SJ, Anaya-Galindo R, Bennet J, Colman RW, Cooper RA (1975) Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 55: 636–643
Lees RS, Carvalho ACA (1978) Hypercholesterolemia and platelets. Adv Exp Med Biol 104: 301–308
Kalofoutis A, Lekakis J (1981) Changes of platelet phospholipids in diabetes mellitus. Diabetologia 21: 540–543
Hornstra G (1973) Dietary fats and arterial thrombosis. Haemostasis 2: 21–52
O'Brien JR, Etherington MD, Jamieson S, Vergroesen AJ, Ten Hoor F (1976) Effect of a diet of polyunsaturated fats on some platelet-function tests. Lancet II: 995–997
Needleman P, Whitaker MO, Wyche A, Watters K, Sprecher H, Raz A (1980) Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: pharmacological basis for a therapeutic approach. Prostaglandins 19: 165–181
Elin RJ (1980) Role of magnesium in membranes: erythrocyte and platelet function and stability. Magnesium in health and disease. Spectrum Publications, pp 115–124
Kobbah M, Vessby B, Tuvemo T (1988) Serum lipids and apolipoproteins in children with Type 1 (insulin-dependent) diabetes during the first two years of the disease. Diabetologia 31: 195–200
Virella G, Wohltmann H, Sagel J, Lopes-Virella MFL, Kilpatrick M, Philips C, Colwell J (1981) Soluble immune complexes in patients with diabetes mellitus: detection and pathological significance. Diabetologia 21: 184–191
Ewald U, Kobbah M, Vessby B, Tuvemo T (1983) Increased platelet aggregability in diabetic children: relation to serum lipid and fatty acid composition. Diabetologia 25: 382–385
Ewald U, Tuvemo T, Rooth G (1981) Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode. Lancet I: 1127–1128
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929
Kylberg E, Ewald U, Tuvemo T, Gebre-Medhin M (1985) Dietary intake in Swedish diabetic children. Acta Paediatr Scand 320: 32–37
Kobbah AM, Hellsing K, Tuvemo T (1988) Early changes of some serum proteins and metals in diabetic children. Acta Paediatr Scand 77: 734–740
Janka HU, Demmel P (1981) Influence of metabolic control on platelet functions in diabetes mellitus. Horm Metab Res 11 [Suppl.]: 29–33
Kobbah M, Ewald U, Tuvemo T (1985) Platelet aggregation during the first year of diabetes in childhood. Acta Paediatr Scand [Suppl.] 320: 50–55
Heyns AP, Elder A, Yarom R, Marx G (1985) Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis. Blood 66: 213–219
Chung YH, Knapp DR, Halushka PV (1978) The effects of alpha adrenergic agents on human platelet aggregation. J Pharm Exp Therap 208: 366–370
Corby DG, O'Barr TP (1981) Decreased alpha-adrenergic receptors in newborn platelets: causes of abnormal response to epinephrine. Dev Pharmacol Ther 2: 215–225
Mackie J, Pittilo RM (1985) Vascular integrity and platelet function. Int Anesth Clin 23: 3–21
Best LC, Holland TK, Jones PBB, Russell RGG (1980) The inter-relationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Thrombos Haemostas (Stuttgart) 43: 38–40
Micic J, Nesovic M, Djordjevic P, Micic D, Popovic M, Jancic M (1979) Plasma triglyceride levels and platelet aggregation in diabetes mellitus. In: Waldhäusl W, Alberti KGMM (eds) Abstracts: 10th Congress of the IDF. International Congress series 481, Excerpta Medica, p 409
Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frölich JC, Heimberg M, Oates JA (1975) Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Therapeut 18: 521–529
Dyerberg J, Bang HO (1979) Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis 8: 227–233
Kobbah AM, Ewald U, Tuvemo T (1988) Impaired vascular reactivity during the first two years of diabetes mellitus after initial restoration. Diabetes Res 8: 101–109
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobbah, A.M., Ewald, U. & Tuvemo, T. Platelet aggregability during the first two years of Type 1 (insulin-dependent) diabetes mellitus in children. Diabetologia 32, 729–735 (1989). https://doi.org/10.1007/BF00274532
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274532